NeomedicS.A.Active

The main business activity of Neomedic focuses on activities of head office and holding companies, excluding financial holding companies.

The company was registered in the Polish National Court Register (KRS) on December 21, 2016.

The headquarters is located at: Al. Gen. Tadeusza Bora-Komorowskiego 25C, 31-476 Kraków.

The management board consists of: Paweł Grzegorz Piszczek (Member of the Management Board) and Tomasz Wiśniewski (President of the Management Board).

The share capital of the company is PLN 2,541,500 (approx. $686,521).

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

The company reported a revenue of $7,623,562 in 2024, which is an increase of 374.2% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $6,574,470, representing a multi-fold increase compared to 2023.

The largest operating cost category falls under employee remuneration. This category amounted to $532,933 in 2024, representing 44% of all operating expenses.